Related Experiment Video

Updated: Aug 23, 2026

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells
09:02

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells

Published on: June 5, 2020

[A pluridisciplinary point of view of hepatitis C virus infections]

Philipe Halfon1, Denis Ouzan, Laurent Cattan

  • 1Département de virologie, Laboratoire Alphabio, Marseille. alphabio@wanadoo.fr

Presse Medicale (Paris, France : 1983)
|July 6, 2004
PubMed

Insights

Effective hepatitis C virus (HCV) infection management requires collaboration among healthcare professionals. Key questions involve screening, diagnostic tests like RNA HCV, and post-treatment follow-up.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Clinical Management

Context:

  • Hepatitis C virus (HCV) infection management involves a multidisciplinary approach.
  • Coordination between virologists, general practitioners, hepato-gastroenterologists, and hospital residents is essential.
  • The biologist's role is critical in diagnostic testing (RNA HCV), prognosis, and guiding therapeutic strategies (genotyping, Fibrotest, Actitest).

Purpose:

  • To outline the collaborative roles of various healthcare professionals in managing HCV infections.
  • To emphasize the importance of integrated care pathways for optimal patient outcomes.
  • To address key questions regarding screening, diagnostic workup, and follow-up for HCV.

Summary:

  • General practitioners are integral throughout the management process, including recognizing and managing co-existing conditions.
  • Hepatologists and general practitioners are key partners, with specialists focusing on patients undergoing treatment.
  • Essential considerations include screening criteria, diagnostic investigations post-serology, and comprehensive follow-up protocols during and after anti-HCV therapy.

Impact:

  • Improved patient care through coordinated multidisciplinary efforts in HCV management.
  • Enhanced diagnostic accuracy and therapeutic decision-making by leveraging specialist expertise.
  • Clearer guidelines for screening, workup, and follow-up, potentially leading to better treatment outcomes and reduced HCV transmission.

More Related Videos

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection11:14

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection

Published on: November 7, 2018

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Human Virome01:26

Human Virome

The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible only with...